Completed PHASE4 NCT00263458

Integrating Buprenorphine Into the SFGH AIDS Program

Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study)

Sponsor: Health Resources and Services Administration (HRSA)

Conditions Buprenorphine HIV Opioid Dependence

Interventions Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting

Updated 5 times since 2017 Last updated: Sep 8, 2011 Started: Dec 31, 2005 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009

A PHASE4 clinical study on Buprenorphine and HIV, this trial is completed. The trial is conducted by Health Resources and Services Administration (HRSA) and has accumulated 5 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Health Resources and Services Administration (HRSA)
San Francisco Department of Public Health
The New York Academy of Medicine
University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States